Author:
Watanabe Ayako,Takagi Mio,Murata Shigeo,Kato Masaru
Funder
Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan
JSPS Core-to-Core Program, A. Advanced Research Networks
Subject
Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry
Reference27 articles.
1. Nanoparticle-based medicines: a review of FDA-approved materials and clinical trials to date;Bobo;Pharm. Res.,2016
2. Liposomal drug delivery system − A review;Deepthi;RGUHS J. Pharm. Sci.,2014
3. Is it equivalent? Evaluation of the clinical activity of single agent Lipodox® compared to single agent Doxil® in ovarian cancer treatment;Smith;J. Oncol. Pharm. Pract.,2016
4. An integrated assessment of morphology, size, and complement activation of the PEGylated liposomal doxorubicin products Doxil®, Caelyx®, DOXOrubicin, and SinaDoxosome;Wibroe;J. Control Release,2016
5. New lipid nanocapsules exhibit sustained release properties for amiodarone;Lamprecht;J. Control Release,2002
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献